Mukherjee et al. demonstrated that both genetic and pharmacologic inhibition of MPTP opening (using the Cyclophilin D-deficient Ppif gene knockout mice, or in vivo treatment with cyclosporine A derivates, respectively) significantly ameliorated pancreatic damage in different experimental AP models in mice [77]. Here, PPIF is linked to alkaline phosphatase measurement.